4//SEC Filing
Obrocea Mihail 4
Accession 0001127602-22-022737
CIK 0001878313other
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 11:13 AM ET
Size
5.2 KB
Accession
0001127602-22-022737
Insider Transaction Report
Form 4
Obrocea Mihail
Chief Medical Officer
Transactions
- Award
Stock Options
2022-09-16+100,000→ 100,000 totalExercise: $3.56Exp: 2032-09-16→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The stock options, granted on September 16, 2022 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of grant and the remaining options to vest ratably monthly thereafter for 36 months.
Documents
Issuer
MAIA Biotechnology, Inc.
CIK 0001878313
Entity typeother
Related Parties
1- filerCIK 0001913265
Filing Metadata
- Form type
- 4
- Filed
- Sep 19, 8:00 PM ET
- Accepted
- Sep 20, 11:13 AM ET
- Size
- 5.2 KB